Brian Mooney
Geschäftsführer bei ProSciento, Inc.
Profil
Brian Mooney is currently the Chief Operating Officer at ProSciento, Inc. Prior to this, he worked as the Director-Project Management at Pharmaceutical Research Associates, Inc., Program Director at Covance Clinical & Periapproval Services SRL, and Senior Vice President-Global Clinical Development at Theorem Clinical Research, Inc. He completed his undergraduate degree from Notre Dame High School Trenton NJ, Inc.
Aktive Positionen von Brian Mooney
| Unternehmen | Position | Beginn |
|---|---|---|
ProSciento, Inc.
 ProSciento, Inc. Miscellaneous Commercial ServicesCommercial Services ProSciento, Inc. is a full-service clinical research organization that works with biopharma companies worldwide to support their outsourced clinical research needs. The company is based in Chula Vista, CA, and has subsidiaries in the United States. The company specializes in providing comprehensive and customized services for multinational, early development clinical trial programs for metabolic continuum diseases, including diabetes, obesity, and steatotic liver disease. ProSciento has conducted over 300 clinical projects and supported the development of many approved metabolic drugs and devices on the market. ProSciento was founded in 2003, and Marcus Hompesch has been the CEO of the company since its inception. | Geschäftsführer | - |
Ehemalige bekannte Positionen von Brian Mooney
| Unternehmen | Position | Ende |
|---|---|---|
Pharmaceutical Research Associates, Inc.
 Pharmaceutical Research Associates, Inc. Miscellaneous Commercial ServicesCommercial Services Pharmaceutical Research Associates, Inc. engages in the provision of clinical research services. It focuses on therapeutic, global regulatory affairs, and pharmacovigilance and patient safety. The company was founded in 1982 and is headquartered in Raleigh, NC. | Corporate Officer/Principal | - |
| Covance Clinical & Periapproval Services SRL | Corporate Officer/Principal | - |
Theorem Clinical Research, Inc.
 Theorem Clinical Research, Inc. Medical/Nursing ServicesHealth Services Theorem Clinical Research, Inc. is a contract research organization that provides core clinical research and development services. The company was founded in 1985 and is headquartered in King of Prussia, PA. | Corporate Officer/Principal | - |
Ausbildung von Brian Mooney
| Notre Dame High School Trenton NJ, Inc. | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Theorem Clinical Research, Inc.
Theorem Clinical Research, Inc. Medical/Nursing ServicesHealth Services Theorem Clinical Research, Inc. is a contract research organization that provides core clinical research and development services. The company was founded in 1985 and is headquartered in King of Prussia, PA. | Health Services |
Pharmaceutical Research Associates, Inc.
Pharmaceutical Research Associates, Inc. Miscellaneous Commercial ServicesCommercial Services Pharmaceutical Research Associates, Inc. engages in the provision of clinical research services. It focuses on therapeutic, global regulatory affairs, and pharmacovigilance and patient safety. The company was founded in 1982 and is headquartered in Raleigh, NC. | Commercial Services |
| Covance Clinical & Periapproval Services SRL | |
ProSciento, Inc.
ProSciento, Inc. Miscellaneous Commercial ServicesCommercial Services ProSciento, Inc. is a full-service clinical research organization that works with biopharma companies worldwide to support their outsourced clinical research needs. The company is based in Chula Vista, CA, and has subsidiaries in the United States. The company specializes in providing comprehensive and customized services for multinational, early development clinical trial programs for metabolic continuum diseases, including diabetes, obesity, and steatotic liver disease. ProSciento has conducted over 300 clinical projects and supported the development of many approved metabolic drugs and devices on the market. ProSciento was founded in 2003, and Marcus Hompesch has been the CEO of the company since its inception. | Commercial Services |
